Case ReportTreatment of a Patient with Abdominal Aortic Aneurysm and Hepatocellular Carcinoma
Section snippets
Case Report
A 78-year-old man was admitted for the treatment of a 65-mm asymptomatic aneurysm of the abdominal aorta. An abdominal ultrasonography revealed a primary liver tumor located in the right liver lobe. An abdominal multidetector-computerized tomography (MDCT) demonstrated a 7 × 6 cm tumor occupying liver segment VI and VII having typical radiologic characteristics of hepatocellular carcinoma (HCC)—arterial enhancement and wash-out on portal phase. No extrahepatic spread was found on abdominal MDCT
Discussion
This case report deals with the successful treatment of a patient with AAA and HCC undergoing simultaneous open repair of the aneurysm and liver resection.
When 2 such life-threatening diseases coexist in the same patient, it is essential to study the operative indications for each disease and carefully plan an appropriate treatment strategy. For optimal plan, there are 3 main issues to address: the risk of aneurysmal rupture if the repair is delayed because of initial resection of the malignant
References (15)
- et al.
Abdominal aortic aneurysm and hepatocellular carcinoma: a one-stage approach
HPB (Oxford)
(2002) - et al.
Endovascular strategy for the elective treatment of concomitant aortoiliac aneurysm and symptomatic large bowel diverticular disease
Ann Vasc Surg
(2014) - et al.
Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases
Hepatology
(2000) - et al.
Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers
J Am Coll Surg
(2007) - et al.
Surgery for abdominal aortic aneurysms associated with malignancy
Surg Today
(1996) - et al.
Abdominal aortic aneurysm combined with a second intraabdominal nonvascular disease–a clinical study and surgical treatment
Swiss Surg
(1996) - et al.
Combined abdominal aortic aneurysmectomy and other abdominal operations
Scand J Surg
(2004)
Cited by (1)
The patient provided informed consent for this study.